• Email Us: [email protected]
  • Contact Us: +1 718 874 1545
  • Skip to main content
  • Skip to primary sidebar

Medical Market Report

  • Home
  • All Reports
  • About Us
  • Contact Us

Sainsbury’s stock higher on hopes of interest from Morrisons loser

October 4, 2021 by David Barret Leave a Comment

October 4, 2021

LONDON (Reuters) -Shares in British supermarket group Sainsbury’s rose as much as 3.7% on Monday on hopes SoftBank’s Fortress Investment, which lost out in the auction for Morrisons, may turn its attention to an even bigger player in UK grocery.

Sainsbury’s stock was up 4.2 pence at 288.9 pence at 0858 GMT, valuing the business at 6.7 billion pounds ($9.1 billion).

Fortress was defeated in Saturday’s shootout for Morrisons, Britain’s No. 4 supermarket group, bidding 286 pence a share – a penny less than rival Clayton, Dubilier & Rice.

However, managing partner Joshua A Pack signalled Fortress remained interested in UK assets.

“The UK remains a very attractive investment environment from many perspectives, and we will continue to explore opportunities to help strong management teams grow their businesses and create long-term value,” he said in a statement.

A spokesperson for Fortress declined to comment on Sainsbury’s, which trails only market leader Tesco in UK grocery sales.

A Sainsbury’s spokesperson also declined to comment.

Shares in Sainsbury’s are up 28% this year, buoyed by bid speculation.

That started in April when Czech billionaire Daniel Kretinsky raised his stake in Sainsbury’s to just under 10% and has been fuelled by the bid battle for Morrisons and signs CEO Simon Roberts’s “food first” strategy is starting to work.

($1 = 0.7381 pounds)

(Reporting by James Davey, editing by Ed Osmond)

Source Link Sainsbury’s stock higher on hopes of interest from Morrisons loser

David Barret
David Barret

Related posts:

  1. HPE signs multi-billion dollar NSA computing deal
  2. EU’s chief executive warns against ‘pandemic of the unvaccinated’
  3. Ghana’s economy grew by 8.9% in second quarter, president says
  4. U.S. chipmaker Micron forecasts first-quarter revenue below estimates

Filed Under: News

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

  • Plastic Chemicals May Delay The Internal Body Clock By 17 Minutes, According To Study
  • Widespread Availability Of RSV Vaccine Linked To Fall In Baby Hospitalizations
  • How Often Should You Wash Your Bedding?
  • What’s The Youngest Language In The World?
  • Look Alert: The Most Active Volcano In the Pacific Northwest Is Probably About To Blow, Maybe
  • Should We Be Using Microwaves?
  • What Is The Largest Deer On Earth?
  • World’s First CRISPR-Edited Spider Produces Glowing Red Silk From Its Spinneret
  • First Ever Image Of “Free Floating” Atoms, The Nocebo Effect Beats The Placebo Effect When It Comes To Pain, And Much More This Week
  • 165-Million-Year-Old Fossil Is New Species Of Ancient Parasite. Did It Come From A Dinosaur’s Butt?
  • It’s True: Time Really Does Move Slower When You’re Exercising
  • Salmon Make Some Of The Most Epic Migrations In Nature. Why Do They Bother?
  • The Catholic Apostolic Church In Albury Has Been Sealed “Until The Second Coming”
  • The Voynich Manuscript Appears To Follow Zipf’s Law. Could It Be A Real Language?
  • When Will All Life On Earth Die Out? Here’s What The Data Says
  • One Of The World’s Rarest And Most Endangered Mammals Is *Checks Notes* A Unicorn
  • Neanderthals Used World’s Oldest Wooden Spears To Hunt Horses 200,000 Years Ago
  • Striking Results Show Neanderthal Crafters Were Sharper Than We Thought
  • Pioneering Research Reveals How Darkness And Light Made The Parthenon Appear Divine
  • Peculiar Material Revealed To Have Hidden Quantum State That Can’t Be Flipped In A Mirror
  • Business
  • Health
  • News
  • Science
  • Technology
  • +1 718 874 1545
  • +91 78878 22626
  • [email protected]
Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.

Powered by Prudour Network

Copyrights © 2025 · Medical Market Report. All Rights Reserved.

Go to mobile version